Beranda4142 • TPE
add
Adimmune Corp
Tutup sebelumnya
NT$19,30
Rentang hari
NT$19,10 - NT$19,40
Rentang tahun
NT$15,90 - NT$26,60
Kapitalisasi pasar
8,25 M TWD
Volume Rata-Rata
1,73 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
TPE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (TWD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 475,32 jt | -46,49% |
Biaya operasional | 146,27 jt | -14,74% |
Penghasilan bersih | -18,26 jt | -106,93% |
Margin laba bersih | -3,84 | -112,96% |
Penghasilan per saham | — | — |
EBITDA | -19,68 jt | -106,24% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (TWD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,79 M | -3,29% |
Total aset | 8,38 M | -2,80% |
Total liabilitas | 3,53 M | 18,40% |
Total ekuitas | 4,85 M | — |
Saham yang beredar | 421,51 jt | — |
Harga terhadap nilai buku | 1,72 | — |
Tingkat pengembalian aset | -1,86% | — |
Tingkat pengembalian modal | -1,94% | — |
Arus Kas
Perubahan kas bersih
| (TWD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -18,26 jt | -106,93% |
Kas dari operasi | -355,08 jt | -17,80% |
Kas dari investasi | -173,61 jt | -102,13% |
Kas dari pembiayaan | 403,21 jt | 5.593,35% |
Perubahan kas bersih | -117,89 jt | 70,35% |
Arus kas bebas | -460,83 jt | -29,17% |
Tentang
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Didirikan
1965
Situs
Karyawan
564
